149 results
424B5
6y4mvk6ulxlh9elysom5
5 Jan 24
Prospectus supplement for primary offering
5:15pm
424B5
76zdz9ffwdqxe
4 Jan 24
Prospectus supplement for primary offering
6:24pm
S-3ASR
6yaub
8 Sep 23
Automatic shelf registration
4:31pm
8-K
EX-10.1
92qyr ptl05hp5y678s
23 Jun 23
Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
4:31pm
8-K
EX-10.2
hvlf60oos1i3
23 Jun 23
Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
4:31pm
8-K
EX-99.1
7chmaayw4tgc0 4vxx6
30 May 23
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
4:32pm
8-K
njeqjr
30 May 23
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
4:32pm
8-K/A
EX-99.2
dsrvs46bz65i 46i28lm
10 Apr 23
Financial Statements and Exhibits
4:30pm